Table 1.
Strengths and limitations of multimodality imaging techniques in diabetic cardiomyopathy.
Modality | Strength | Limitation |
---|---|---|
Echocardiography | • High temporal and spatial resolutions, accessibility, affordability, harmlessness • Effective in detecting early diastolic dysfunction • Critical for early detection and monitoring of DMCM |
• Operator-dependent diagnostic accuracy • Compromised image quality in patients with poor acoustic windows • Limited information on myocardial tissue characterization and metabolism |
Cardiac MRI | • Higher spatial and temporal resolution, assesses myocardial fibrosis and altered metabolism • Can identify myocardial scar tissue and abnormal diastolic function • Comprehensive tissue characterization, high-resolution imaging |
• Perceived expense burden, patient comfort issues, longer examination times • Risk of nephrogenic systemic fibrosis with older generation Gadolinium-based contrast media |
Nuclear Imaging | • Detects low-density processes, measures myocardial metabolism, assesses molecular imaging • Flexible radiotracer design, accurate radiotracer localization with combined techniques • Reveals significant metabolic alterations in DMCM |
• High cost and limited availability • Low spatial resolution compared to CMR, concerns about radiation exposure • Requires specialized expertise for interpretation |